FULC · Fulcrum Therapeutics, Inc.
AI read · Good for FULC
The AI's read
The sale would turn early-stage assets into cash and increase a dividend expected with the merger. That gives Fulcrum shareholders a possible cash benefit. The sale has not closed and depends on the merger, or required approvals if the merger agreement ends.